India Conjugate Vaccine Market Size, Trends, Growth, Forecast period 2018-2023
A Comprehensive research study conducted by KD Market Insights on "India Conjugate Vaccine Market 2018" report offers extensive and highly detailed historical, current and future market trends in the global and regional/market. The Conjugate Vaccine market report includes market size, growth drivers, barriers, opportunities, trends and other information which helps to find new opportunities in this market for the growth of the business through new technologies and developments.
Conjugate vaccine is a type of vaccine that contains bacterial capsular polysaccharide, attached to a protein to enhance immunogenicity and protects against invasive diseases. India is one of the most prominent markets of conjugate vaccines. India is expected to be the fastest growing market due to the government’s focus on research and development in the life sciences domain. By making Pneumococcal Conjugate Vaccine (PCV) available under the Universal immunization program (UIP), the government of India is ensuring equitable access to those who need them the most – the underprivileged and underserved. Hib is one of the leading causes of bacterial meningitis in India and a major cause of childhood pneumonia. The introduction of LPV in India is a significant milestone and a step forward towards accelerating child survival in India, and progress towards achieving national health goals and the Millennium Development Goal 4.
Request for Sample@ https://www.kdmarketinsights.com/sample/3243
Market Segmentation:
o Based on disease indication, the market is segmented into pneumococcal, haemophilus influenza type b, diphtheria-tetanus-pertussis, meningococcal and others.
o Based on end user, the market is segmented into paediatric and adult.
Key growth factors:
India is projected to be the fastest growing market for conjugate vaccines during the forecast period. Rapidly increasing population, rise in consumer awareness, growing disposable income and healthcare expenditure, modernization of healthcare infrastructure, and a growing medical tourism industry will drive the growth of the Indian market.
Threats and key players:
o The India conjugate vaccine market is expected to have significantly high growth. Delayed introduction of conjugate vaccines is likely to hold back the conjugate vaccine market. Though the prevalence of chronic diseases is high, limited availability and accessibility of conjugate vaccines in remote areas can become a cause for concern. Complicated manufacturing can also be a major restraint for this market.
o Major conjugate vaccine providers operating in the market are GlaxoSmithKline, Pfizer Inc., Merck, Novartis, Sanofi Pasteur, etc.
What’s covered in the report?
1. Overview of the India conjugate vaccine market
2. Market drivers and challenges in the India conjugate vaccine market
3. Market trends in India conjugate vaccine market
4. Historical, current and forecasted market size data for India based on disease indication (pneumococcal, haemophilus influenza type b, diphtheria-tetanus-pertussis, meningococcal conjugate vaccines) – by revenue and by volume
5. Historical, current and forecasted market size data for India based on end user (paediatric and adult conjugate vaccines) – by revenue and by volume
6. Analysis of the competitive landscape and profiles of major companies operating in the Indian market
Why buy?
o Understand the demand for conjugate vaccines to determine the viability of the market
o Develop strategies based on the drivers and trends for each of the segments
o Evaluate the value chain to define the workflow and to get an idea of the current position where you are placed
o Recognize the key competitors of this market and respond accordingly
o Identify the initiatives and growth strategies taken up by the major companies and decide on the direction for further growth
o Define the competitive positioning by comparing the products and services with the key players in the market
Browse Full Report With TOC@ https://www.kdmarketinsights.com/product/india-conjugate-vaccine-market
Table of Contents:
Chapter 1: Executive summary
1.1 Market scope and segmentation
1.2 Key questions answered in this study
1.3 Executive summary - I
1.4 Executive summary – II
Chapter 2: Market overview
2.1. Market definitions
2.2. India market overview – by revenue
- India historical (2015-2017) market revenue (USD Bn)
- India forecasted (2018-2023) market revenue (USD Bn)
2.3. India market overview – by volume
- India historical (2015-2017) market volume (Million units)
- India forecasted (2018-2023) market volume (Million units)
2.4. India market drivers and challenges
2.4.1. India market drivers
2.4.2. India market challenges
2.5. India market trends
2.6. Value chain
Chapter 3: India major segment overview - by disease indication
3.1. Disease indication: Pneumococcal, Hib - by revenue, by volume, CAGR
- Overview - by disease indication
- Market share (2015, 2018 & 2023): Pneumococcal – India (USD Bn, Million units)
- Market share (2015, 2018 & 2023): Hib – India (USD Bn, Million units)
3.2. Disease indication: DTP, Meningococcal - by revenue, by volume, CAGR
- Overview - by disease indication
- Market share (2015, 2018 & 2023): DTP – India (USD Bn, Million units)
- Market share (2015, 2018 & 2023): Meningococcal – India (USD Bn, Million units)
Chapter 4: India major segment overview - by end user
4.1. End-user: Pediatric, Adult - by revenue, by volume, CAGR
- Overview - by end user
- Market share (2015, 2018 & 2023): Paediatric – India (USD Bn, Million units)
- Market share (2015, 2018 & 2023): Adult – India (USD Bn, Million units)
Chapter 5: Competitive landscape
5.1. Company market share
- Top 5 companies
5.2. Company overview - GlaxoSmithKline
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
5.2(A) Executive profile – GlaxoSmithKline
5.3. Company overview – Pfizer Inc.
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
5.3(A) Executive profile - Pfizer Inc.
5.4. Company overview – Merck & Co.
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
5.4(A) Executive profile - Merck & Co.
5.5. Company overview – Novartis
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
5.5(A) Executive profile - Novartis
5.6. Company overview – Sanofi Pasteur
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
5.6(A) Executive profile - Sanofi Pasteur
5.7. Company overview – CSL Limited
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
5.7(A) Executive profile - CSL Limited
5.8. Company overview – Bharat Biotech
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
5.8(A) Executive profile – Bharat Biotech
5.9. Company overview – Biological E. Limited
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
5.9(A) Executive profile – Biological E. Limited
5.10. Company overview – Serum Institute of India
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
5.10(A) Executive profile – Serum Institute of India
Appendix
- List of tables
- Assumptions
- Conclusion
- Research methodology
- About Netscribes Inc.
Continue@.....
Check For Discount@ https://www.kdmarketinsights.com/discount/3243
About Us:
KD Market Insights offers a comprehensive database of syndicated research studies, customized reports, and consulting services. These reports are created to help in making smart, instant and crucial decisions based on extensive and in-depth quantitative information, supported by extensive analysis and industry insights.
Our dedicated in-house team ensures the reports satisfy the requirement of the client. We aim at providing value service to our clients. Our reports are backed by extensive industry coverage and is made sure to give importance to the specific needs of our clients. The main idea is to enable our clients to make an informed decision, by keeping them and ourselves up to date with the latest trends in the market.
Contact Us:
KD Market Insights
150 State Street, Albany,
New York, USA 12207
Telephone: +1 (518) 300-1215
Email: sales@kdmarketinsights.com
Website: www.kdmarketinsights.com
Follow us - Facebook, Twitter, Linked In
Conjugate vaccine is a type of vaccine that contains bacterial capsular polysaccharide, attached to a protein to enhance immunogenicity and protects against invasive diseases. India is one of the most prominent markets of conjugate vaccines. India is expected to be the fastest growing market due to the government’s focus on research and development in the life sciences domain. By making Pneumococcal Conjugate Vaccine (PCV) available under the Universal immunization program (UIP), the government of India is ensuring equitable access to those who need them the most – the underprivileged and underserved. Hib is one of the leading causes of bacterial meningitis in India and a major cause of childhood pneumonia. The introduction of LPV in India is a significant milestone and a step forward towards accelerating child survival in India, and progress towards achieving national health goals and the Millennium Development Goal 4.
Request for Sample@ https://www.kdmarketinsights.com/sample/3243
Market Segmentation:
o Based on disease indication, the market is segmented into pneumococcal, haemophilus influenza type b, diphtheria-tetanus-pertussis, meningococcal and others.
o Based on end user, the market is segmented into paediatric and adult.
Key growth factors:
India is projected to be the fastest growing market for conjugate vaccines during the forecast period. Rapidly increasing population, rise in consumer awareness, growing disposable income and healthcare expenditure, modernization of healthcare infrastructure, and a growing medical tourism industry will drive the growth of the Indian market.
Threats and key players:
o The India conjugate vaccine market is expected to have significantly high growth. Delayed introduction of conjugate vaccines is likely to hold back the conjugate vaccine market. Though the prevalence of chronic diseases is high, limited availability and accessibility of conjugate vaccines in remote areas can become a cause for concern. Complicated manufacturing can also be a major restraint for this market.
o Major conjugate vaccine providers operating in the market are GlaxoSmithKline, Pfizer Inc., Merck, Novartis, Sanofi Pasteur, etc.
What’s covered in the report?
1. Overview of the India conjugate vaccine market
2. Market drivers and challenges in the India conjugate vaccine market
3. Market trends in India conjugate vaccine market
4. Historical, current and forecasted market size data for India based on disease indication (pneumococcal, haemophilus influenza type b, diphtheria-tetanus-pertussis, meningococcal conjugate vaccines) – by revenue and by volume
5. Historical, current and forecasted market size data for India based on end user (paediatric and adult conjugate vaccines) – by revenue and by volume
6. Analysis of the competitive landscape and profiles of major companies operating in the Indian market
Why buy?
o Understand the demand for conjugate vaccines to determine the viability of the market
o Develop strategies based on the drivers and trends for each of the segments
o Evaluate the value chain to define the workflow and to get an idea of the current position where you are placed
o Recognize the key competitors of this market and respond accordingly
o Identify the initiatives and growth strategies taken up by the major companies and decide on the direction for further growth
o Define the competitive positioning by comparing the products and services with the key players in the market
Browse Full Report With TOC@ https://www.kdmarketinsights.com/product/india-conjugate-vaccine-market
Table of Contents:
Chapter 1: Executive summary
1.1 Market scope and segmentation
1.2 Key questions answered in this study
1.3 Executive summary - I
1.4 Executive summary – II
Chapter 2: Market overview
2.1. Market definitions
2.2. India market overview – by revenue
- India historical (2015-2017) market revenue (USD Bn)
- India forecasted (2018-2023) market revenue (USD Bn)
2.3. India market overview – by volume
- India historical (2015-2017) market volume (Million units)
- India forecasted (2018-2023) market volume (Million units)
2.4. India market drivers and challenges
2.4.1. India market drivers
2.4.2. India market challenges
2.5. India market trends
2.6. Value chain
Chapter 3: India major segment overview - by disease indication
3.1. Disease indication: Pneumococcal, Hib - by revenue, by volume, CAGR
- Overview - by disease indication
- Market share (2015, 2018 & 2023): Pneumococcal – India (USD Bn, Million units)
- Market share (2015, 2018 & 2023): Hib – India (USD Bn, Million units)
3.2. Disease indication: DTP, Meningococcal - by revenue, by volume, CAGR
- Overview - by disease indication
- Market share (2015, 2018 & 2023): DTP – India (USD Bn, Million units)
- Market share (2015, 2018 & 2023): Meningococcal – India (USD Bn, Million units)
Chapter 4: India major segment overview - by end user
4.1. End-user: Pediatric, Adult - by revenue, by volume, CAGR
- Overview - by end user
- Market share (2015, 2018 & 2023): Paediatric – India (USD Bn, Million units)
- Market share (2015, 2018 & 2023): Adult – India (USD Bn, Million units)
Chapter 5: Competitive landscape
5.1. Company market share
- Top 5 companies
5.2. Company overview - GlaxoSmithKline
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
5.2(A) Executive profile – GlaxoSmithKline
5.3. Company overview – Pfizer Inc.
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
5.3(A) Executive profile - Pfizer Inc.
5.4. Company overview – Merck & Co.
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
5.4(A) Executive profile - Merck & Co.
5.5. Company overview – Novartis
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
5.5(A) Executive profile - Novartis
5.6. Company overview – Sanofi Pasteur
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
5.6(A) Executive profile - Sanofi Pasteur
5.7. Company overview – CSL Limited
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
5.7(A) Executive profile - CSL Limited
5.8. Company overview – Bharat Biotech
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
5.8(A) Executive profile – Bharat Biotech
5.9. Company overview – Biological E. Limited
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
5.9(A) Executive profile – Biological E. Limited
5.10. Company overview – Serum Institute of India
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
5.10(A) Executive profile – Serum Institute of India
Appendix
- List of tables
- Assumptions
- Conclusion
- Research methodology
- About Netscribes Inc.
Continue@.....
Check For Discount@ https://www.kdmarketinsights.com/discount/3243
About Us:
KD Market Insights offers a comprehensive database of syndicated research studies, customized reports, and consulting services. These reports are created to help in making smart, instant and crucial decisions based on extensive and in-depth quantitative information, supported by extensive analysis and industry insights.
Our dedicated in-house team ensures the reports satisfy the requirement of the client. We aim at providing value service to our clients. Our reports are backed by extensive industry coverage and is made sure to give importance to the specific needs of our clients. The main idea is to enable our clients to make an informed decision, by keeping them and ourselves up to date with the latest trends in the market.
Contact Us:
KD Market Insights
150 State Street, Albany,
New York, USA 12207
Telephone: +1 (518) 300-1215
Email: sales@kdmarketinsights.com
Website: www.kdmarketinsights.com
Follow us - Facebook, Twitter, Linked In
Comments
Post a Comment